// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A study on the incidence of CMV PCR positivity in adult CMV negative recipients receiving CMV negative donor allogeneic haematopoietic stem cell transplants

R Evans - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

The value of simplification of the electronic prescription process on the rate of prescription errors and user experience

J Smith - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Blood donors’ perceptions, motivators and deterrents in Sub‐Saharan Africa – a scoping review of evidence

L Asamoah-Akuoko - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An audit of the ongoing management of confirmed pulmonary embolism at the Bristol Royal Infirmary

J Wolf - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

The United Kingdom Immune Thrombocytopenia Registry: an update and treatment pattern description over time

U Doobaree - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Inferior vena cava filters – capturing current practice in a District General Hospital

N Redding - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Correlation of clinical presentation and D‐dimer values for the positive prediction of pulmonary emboli

J Peters - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Experience of immune tolerance in a carrier of severe haemophilia A with inhibitor development post‐surgery

R Trickey - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Desmopressin

Bleeding and the direct oral anticoagulants (DOACs) in the <55 year group

M Willcocks - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

rivaroxaban

The majority of Hospital Associated Thrombosis (HAT) in 2016 cannot be prevented by application of existing NICE guidance

NMD Mcquaid - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Cardiff and Vale University Health Board Atrial Fibrillation Project “Stop A Stroke (SAS): who cares wins”

R Alikhan - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Methadone hydrochloride

Upper extremity deep vein thrombosis – an increasingly common condition with unique clinical challenges

C Humphrey - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Warfarin

Avoiding platelet transfusion with Eltrombopag in MHY9 related disorder

C Burney - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Tranexamic acid

Safe outpatient management of pulmonary embolism: 2010–2015

H Rowswell - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Extracellular histones inhibit complement activation through interacting with complement component 4

Y Qaddoori - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Inherited bleeding disorders: obstetric management and outcome – a single institution's experience between 2014 and 2016

I Koutsavlis - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Recombinant Factor VIII

Are we missing cancer in unprovoked PE? – An audit on the uptake rate of NICE guidelines for investigating cancer in patients with unprovoked PE

Y Raines - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Inferior vena cava filters in pregnancy: a single centre experience 1995–2015

A Mujalli - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Determining the length of stay in secondary care for patients admitted with deep vein thrombosis or pulmonary embolism

H Roberts - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Heparin

Rituximab induced serum sickness in acute thrombotic thrombocytopenic purpura: a single centre experience

C Vendramin - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Prednisolone

Copyright © 2026. QuantiNova All rights reserved